Repatha 140 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FM1GX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,935
Award facts
- Contract value 100% obligated
- $24,935.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $24,935.10 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Repatha 140 mg/mL SureClick auto-injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. No set-aside designation was applied to this award.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing comprehensive medical supply solutions to federal health systems, including the Defense Health Agency and U.S. Coast Guard. The company's DLA prime contract vehicle supports military healthcare programs globally through the supply of brand-name and generic pharmaceuticals, vaccines, specialty medications, and related medical commodities. Repatha (evolocumab) is a PCSK9 inhibitor indicated for cardiovascular risk reduction in patients with high cholesterol, reflecting the breadth of therapeutic categories supported under the prime contract's pharmaceutical portfolio. This delivery order exemplifies AmerisourceBergen's ongoing role as a critical vendor for federal medical procurement through open competition.
Quick answers
Who was awarded contract SPE2DB25FM1GX?
SPE2DB25FM1GX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FM1GX worth?
The government has obligated $24,935 on SPE2DB25FM1GX.
Is contract SPE2DB25FM1GX an order under another contract?
Yes. SPE2DB25FM1GX is a delivery order under SPE2DB22D2009, an indefinite delivery contract.
Was contract SPE2DB25FM1GX competed?
The extent of competition for SPE2DB25FM1GX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award